Tectonic Therapeutic, Inc. Common Stock
$27.00
-$0.21 (-0.77%)
$26.38Day Range$27.59
Key Statistics
Market Cap
$531.94M
Shares Outstanding
19.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 21, 2024
Round Lot
100
Locale
US
Trading Data
Day Open
$27.30
Day High
$27.59
Day Low
$26.38
Volume
330.6K
VWAP
$27.02
Prev Close
$27.21
Transactions
--
Acc. Volume
--
About Tectonic Therapeutic, Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 283660 employees490 ARSENAL WAY, WATERTOWN, MA(339) 666-3320IPO Jun 21, 2024US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001681087
- Composite FIGI
- BBG00DJ4T7D1
- Share Class FIGI
- BBG00DJ4T7F9
- Ticker Root
- TECX
- SIC Code
- 2836
About Tectonic Therapeutic, Inc. Common Stock (TECX) Stock
Tectonic Therapeutic, Inc. Common Stock (TECX) closed the 2026-09-18 session at $27.00, down 0.77% versus the previous close (-0.21). The stock opened at $27.30 and traded between $26.38 and $27.59 during that session. Session trading volume was 331K shares. The volume-weighted average price (VWAP) is $27.02.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
Tectonic Therapeutic, Inc. Common Stock has a market capitalization of $531.9 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. TECX is listed on the XNAS exchange. The company employs approximately 60 people. Tectonic Therapeutic, Inc. Common Stock is headquartered in WATERTOWN, MA. The recorded listing date is 2024-06-21.
On this page you can find market TECX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.